<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia - Grabosch, SM - 2018 | Cochrane Library</title> <meta content="Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia - Grabosch, SM - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004121.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia - Grabosch, SM - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004121.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004121.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia" name="citation_title"/> <meta content="Shannon M Grabosch" name="citation_author"/> <meta content="Magee‐Womens Hospital of UPMC" name="citation_author_institution"/> <meta content="smgrabosch@gmail.com" name="citation_author_email"/> <meta content="Osman M Shariff" name="citation_author"/> <meta content="University of Louisville School of Medicine" name="citation_author_institution"/> <meta content="C. William Helm" name="citation_author"/> <meta content="Princess Alexandra Wing, Royal Cornwall Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD004121.pub4" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/02/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004121.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004121.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004121.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal [administration &amp; dosage, *therapeutic use]; Celecoxib [therapeutic use]; Cyclooxygenase 2 Inhibitors [administration &amp; dosage, *therapeutic use]; Disease Progression; Induction Chemotherapy [*methods]; Lactones [administration &amp; dosage, therapeutic use]; Placebos [therapeutic use]; Randomized Controlled Trials as Topic; Sulfonamides [administration &amp; dosage, therapeutic use]; Sulfones [administration &amp; dosage, therapeutic use]; Uterine Cervical Dysplasia [*drug therapy, pathology]; Uterine Cervical Neoplasms [*drug therapy, pathology]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004121.pub4&amp;doi=10.1002/14651858.CD004121.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="77cjsSG8";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004121\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004121\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","ja","th","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004121.pub4",title:"Non\\u2010steroidal anti\\u2010inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia",firstPublishedDate:"Feb 12, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecological, Neuro‐oncology and Orphan Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004121.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004121.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004121.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004121.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004121.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004121.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004121.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004121.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004121.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004121.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2488 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004121.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-sec-0074"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-sec-0049"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-sec-0068"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/appendices#CD004121-sec-0079"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/table_n/CD004121StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/table_n/CD004121StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/information#CD004121-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Shannon M Grabosch</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/information#CD004121-cr-0003">Osman M Shariff</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004121.pub4/information#CD004121-cr-0004">C. William Helm</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/information/en#CD004121-sec-0094">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 February 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004121.pub4">https://doi.org/10.1002/14651858.CD004121.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004121-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004121-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004121-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004121-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/th#CD004121-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004121-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004121-abs-0001" lang="en"> <section id="CD004121-sec-0001"> <h3 class="title" id="CD004121-sec-0001">Background</h3> <p>This is an updated version of the original Cochrane review published in 2014, Issue 4. Cervical intraepithelial neoplasia (CIN) precedes the development of invasive carcinoma of the cervix. Current treatment of CIN is quite effective, but there is morbidity for the patient related to pain, bleeding, infection, cervical stenosis and premature birth in a subsequent pregnancy. Effective treatment with medications, rather than surgery, would be beneficial. </p> </section> <section id="CD004121-sec-0002"> <h3 class="title" id="CD004121-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of non‐steroidal anti‐inflammatory agents (NSAIDs), including cyclooxygenase‐2 (COX‐2) inhibitors, to induce regression and prevent the progression of CIN. </p> </section> <section id="CD004121-sec-0003"> <h3 class="title" id="CD004121-sec-0003">Search methods</h3> <p>Previously, we searched the Cochrane Gynaecological Cancer Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (2013, Issue 11), MEDLINE (November, 2013) and Embase (November week 48, 2013). An updated search was performed in August 2017 for CENTRAL (2017, Issue 8), MEDLINE (July, week 3, 2017) and Embase (July week 31, 2017). Trial registries and journals were also searched as part of the update. </p> </section> <section id="CD004121-sec-0004"> <h3 class="title" id="CD004121-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) or controlled trials of NSAIDs in the treatment of CIN. </p> </section> <section id="CD004121-sec-0005"> <h3 class="title" id="CD004121-sec-0005">Data collection and analysis</h3> <p>Three review authors independently abstracted data and assessed risks of bias in accordance with Cochrane methodology. Outcome data were pooled using fixed‐effect meta‐analyses. </p> </section> <section id="CD004121-sec-0006"> <h3 class="title" id="CD004121-sec-0006">Main results</h3> <p>In three RCTs, 171 women over the age of 18 years were randomised to receive celecoxib 400 mg daily for 14 to 18 weeks versus placebo (one study, 130 participants), celecoxib 200 mg twice daily by mouth for six months versus placebo (one study, 25 participants), or rofecoxib 25 mg once daily by mouth for three months versus placebo (one study, 16 participants). The study with rofecoxib was discontinued when the medicine was withdrawn from the market in 2004. The trials ran from June 2005 to April 2012, June 2002 to October 2003, and May to October 2004, respectively. We have chosen to include the data from the rofecoxib study as outcomes may be similar when other such NSAIDs are utilised. </p> <p>Partial or complete regression of CIN 2 or CIN 3 occurred in 31 out of 70 (44%) in the treatment arms and 19 of 62 (31%) in the placebo arms (risk ratio (RR) 1.45, 95% confidence interval (CI) 0.93 to 2.27; P value 0.10), three studies, 132 participants; moderate‐certainty evidence). Complete regression of CIN 2 or CIN 3 occurred in 15 of 62 (24%) of those receiving celecoxib versus 10 of 54 (19%) of those receiving placebo (RR 1.31, 95% CI 0.65 to 2.67; P value 0.45, two studies, 116 participants; moderate‐certainty evidence). Partial regression of CIN 2 or CIN 3 occurred in 14 of 62 (23%) of those receiving celecoxib versus 8 of 54 (15%) of those receiving placebo (RR 1.56, 95% CI 0.72 to 3.4; P value 0.26), two studies, 116 participants; moderate‐certainty evidence). </p> <p>Progression to a higher grade of CIN, but not to invasive cancer, occurred in one of 12 (8%) of those receiving celecoxib and two of 13 (15%) receiving placebo (RR 0.54, 95% CI 0.05 to 5.24; P value 0.60, one study, 25 participants; very low‐certainty evidence). Two studies reported no cases of progression to invasive cancer within the timeframe of the study. No toxicity was reported in the two original articles. The trial added in this update had one Grade 3 gastrointestinal adverse effect in the treatment arm, but otherwise had similar Grade 1 to 2 side effects between treatment and placebo groups. Although the studies were well‐conducted and randomised, some risk of bias was detected in all studies. Furthermore, the duration of the studies was short, which may mask identifying progression to cancer. </p> <p>The addition of the trial in this update quadrupled the number of patients in the original review and was a well‐designed multicentre trial thus, increasing the overall certainty of evidence from very low to moderate for this review. </p> </section> <section id="CD004121-sec-0007"> <h3 class="title" id="CD004121-sec-0007">Authors' conclusions</h3> <p>There are currently no convincing data to support a benefit for NSAIDs in the treatment of CIN. With the addition of this new, larger randomised trial we would rate this as overall moderate‐certainty evidence by the GRADE criteria. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004121-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004121-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004121-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004121-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004121-abs-0007">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004121-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD004121-abs-0010">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004121-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004121-abs-0004" lang="en"> <h3>The treatment of cervical pre‐cancer (CIN) with anti‐inflammatory agents to induce regression and prevent the progression to cervical cancer </h3> <p><b>Background</b><br/> This review is an update of a previously published review in The Cochrane Database of Systematic Reviews 2014, Issue 4 on non‐steroidal anti‐inflammatory agents (NSAIDs) to induce regression and prevent the progression of cervical intraepithelial neoplasia (CIN). Cervical intraepithelial neoplasia (CIN) is a common pre‐cancerous condition of the cervix associated with HPV (the human papillomavirus), which can occur in anyone but is commonly found in younger women who wish to maintain their fertility and treatment often involves surgical excision. CIN can progress to invasive cancer of the cervix. CIN is identified by screening and can be treated with surgery to the cervix either by removal with surgical excision or destruction of the cells covering the cervix such as with laser therapy, heating, or freezing. While this is effective in the majority of cases, the surgery can cause immediate unwanted effects, such as bleeding and infection, or later complications including difficulty with menses due to scarring of the cervix and early (premature) labour. </p> <p>NSAIDs have been found to prevent the development of cancer of the large bowel and other organs, but with some unwanted side effects especially on the heart and blood vessels. Although rofecoxib, used in one of these studies, was withdrawn from the market in 2004, it may shed light on the feasibility of treatment with other NSAIDs. </p> <p>We wanted to discover whether the use of NSAIDs for women with CIN could promote regression or prevent progression to cervical cancer without undue risk or side effects. </p> <p><b>The aim of the review</b><br/> To identify the utility of treating CIN with non‐steroidal anti‐inflammatory drugs (NSAIDs) such as celecoxib to cause regression of the abnormal findings and avoid surgical procedures. </p> <p><b>Study characteristics</b><br/> We identified three randomised studies up to August 2017, including 171 women over the age of 18 years, with moderate or severe CIN. The trials ran from June 2005 to April 2012, June 2002 to October 2003, and May to October 2004. One of them was discontinued before it was completed. The women were given either celecoxib or rofecoxib versus a placebo (sugar tablet) daily by mouth for a period of three to six months. </p> <p><b>Key Results</b><br/> With the addition of the third trial to this review, there is now a sufficient number of patients in the review to conclude that NSAIDs have minimal effect over placebo in causing regression of CIN. No patients progressed to invasive cervical cancer, and overall, the drug was well‐tolerated compared to placebo. </p> <p><b>Quality of the evidence</b> <br/> The studies appear to have been well‐conducted. There are some questions related to the quality of evidence in relation to concealment and women dropping out of the study before completion of assigned medications. We therefore concluded that the certainty (quality) of the evidence was moderate. There was insufficient information to assess accuracy of the reporting of information. It is possible that there are other incomplete and unreported studies that have not been identified. </p> <p><b>Conclusion</b><br/> The literature available at this time suggests that there are no convincing data to suggest NSAIDs as a treatment for CIN. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004121-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004121-sec-0074"></div> <h3 class="title" id="CD004121-sec-0075">Implications for practice</h3> <section id="CD004121-sec-0075"> <p>In this updated review, there is sufficient evidence to determine that, while overall safe and well‐tolerated, non‐steroidal anti‐inflammatory agents (NSAIDs) are not efficacious in the treatment of cervical intraepithelial neoplasia (CIN). The addition of the multi‐centre, randomised trial in this review to the two small short‐term studies reviewed previously now provides high‐quality support for these conclusions. For those patients strongly opposed to surgery, an NSAID trial would not be unreasonable but close surveillance should be implemented with surgical intervention if no response is achieved. </p> </section> <h3 class="title" id="CD004121-sec-0076">Implications for research</h3> <section id="CD004121-sec-0076"> <p>Further understanding of the molecular mechanisms and pathways involved in cancer development and the interactions of NSAIDs with these pathways could lead to more effective chemo‐preventive agents without substantial toxicity, and should be pursued. Although there is currently insufficient evidence to promote use of NSAIDs for treatment of CIN, further studies may support a medical management approach, and save women (especially in their child‐bearing years) unnecessary procedures, particularly as personalised, targeted treatment is being emphasised in medicine. Biomarker analysis prior to, and following treatment, could lead to further understanding of regression of CIN seen with NSAIDs. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004121-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004121-sec-0022"></div> <div class="table" id="CD004121-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Non‐steroidal anti‐inflammatory agents (NSAIDs) compared with placebo for CIN 2 or CIN 3</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with CIN 2 or CIN 3 </p> <p><b>Settings:</b> outpatient </p> <p><b>Intervention:</b> celecoxib 400 mg by mouth daily for 14‐18 weeks, celecoxib 200 mg by mouth twice daily for six months or rofecoxib 40 mg by mouth daily for three months </p> <p><b>Comparison:</b> placebo tablet by mouth, daily for three to six months </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Progression of CIN to a higher grade of CIN</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>77 per 1000<sup>1</sup> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>42 per 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.54 (0.06 to 5.24)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 (one study)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<sup>3</sup><br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partial or complete regression of CIN 2 or CIN 3</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>308 per 1000<sup>2</sup> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>447 per 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.45 (0.93 to 2.27)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>132 (three studies)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<sup>3</sup><br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Complete regression of CIN 2 or CIN 3</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>174 per 1000<sup>1</sup> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>228 per 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.31 (0.65 to 2.67)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>116 (two studies)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>3</sup><br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>CIN</b> : cervical intraepithelial neoplasia; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High</b> certainty<b>:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate</b> certainty<b>:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low</b> certainty<b>:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low</b> certainty<b>:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The basis for the assumed risk is from the spontaneous complete regression rate in the placebo arm of <a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a> and <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a> </p> <p><sup>2</sup> The basis for the assumed risk is from the combined spontaneous partial or complete regression rates in the placebo arms of <a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>; <a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>; <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a> </p> <p><sup>3</sup>Given the increased sample size with the addition of <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>, we have upgraded the certainty to high other than the Progression analysis as it is based on one small study and thus remained very low certainty. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004121-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004121-sec-0023"></div> <section id="CD004121-sec-0024"> <h3 class="title" id="CD004121-sec-0024">Description of the condition</h3> <p>This review is an update of a previously published review in The Cochrane Database of Systematic Reviews 2014, Issue 4 on 'Non‐steroidal anti‐inflammatory agents (NSAIDs) to induce regression and prevent the progression of cervical intraepithelial neoplasia' (<a href="./references#CD004121-bbs2-0068" title="GraboschSM , ShariffOM , WulfJL , HelmCW . Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. Cochrane Database of Systematic Reviews2014, Issue 4. [DOI: 10.1002/14651858.CD004121.pub3] ">Grabosch 2014</a>). </p> <p>Invasive carcinoma of the cervix is the most common cancer in women in developing countries with more than 500,000 cases diagnosed worldwide each year (<a href="./references#CD004121-bbs2-0019" title="FerlayJ , ShinH‐R , BrayF , FormanD , MathersC , ParkinDM . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer2010;127(12):2893‐917. [PubMed: : 21351269] ">Ferlay 2010</a>). It is preceded by cervical intraepithelial neoplasia (CIN), which can be detected on cervical cytology screens (Papanicolaou test or Pap smear). Treatment of CIN is effective at reducing, but not eliminating, the risk of subsequent invasive carcinoma (<a href="./references#CD004121-bbs2-0061" title="SoutterWP , deBarros LopesA , FletcherA , MonaghanJM , DuncanID , ParaskevaidisE , et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet1997;349(9057):978‐80. [PUBMED: 9100623] ">Soutter 1997</a>). However, the cost of treatment of CIN and follow‐up is high, and the surgery involved can have short‐ and long‐term adverse effects (<a href="./references#CD004121-bbs2-0010" title="ArbynM , KyrgiouM , SimoensC , RaifuAO , KoliopoulosG , Martin‐HirschP , et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta‐analysis. BMJ2008;337:a1284. [PUBMED: 18801868] ">Arbyn 2008</a>; <a href="./references#CD004121-bbs2-0043" title="Martin‐HirschPPL , ParaskevaidisE , BryantA , DickinsonHO , KeepSL . Surgery for cervical intraepithelial neoplasia. Cochrane Database of Systematic Reviews2013, Issue 12. [DOI: 10.1002/14651858.CD001318.pub3; PUBMED: 20556751] ">Martin‐Hirsch 2010</a>). </p> </section> <section id="CD004121-sec-0025"> <h3 class="title" id="CD004121-sec-0025">Description of the intervention</h3> <p>The family of agents called non‐steroidal anti‐inflammatory agents (NSAIDs), including aspirin, ibuprofen, indomethacin, naproxen, piroxicam, and sulindac (<a href="./references#CD004121-bbs2-0023" title="FischerSM , HawkET , LubetRA . Coxibs and other nonsteroidal anti‐inflammatory drugs in animal models of cancer prevention. Cancer Prevention Research2011;4(11):1728‐35. [PUBMED: 21778329] ">Fischer 2011</a>), are able to block both cyclooxygenase (COX) ‐1 and ‐2 enzymes. Selective COX‐2 inhibitors such as celecoxib, rofecoxib and valdecoxib specifically interfere with COX‐2. These agents can be taken orally. </p> </section> <section id="CD004121-sec-0026"> <h3 class="title" id="CD004121-sec-0026">How the intervention might work</h3> <p>COX enzymes catalyse the rate‐limiting step in the conversion of arachidonic acid to prostaglandins and other eicosanoids (<a href="./references#CD004121-bbs2-0014" title="DeWittDL . Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochimica et Biophysica Acta1991;1083(2):121‐34. [PUBMED: 1903657] ">DeWitt 1991</a>). COX‐1 is involved in homeostatic functions such as gastrointestinal cytoprotection and is constitutively expressed in most tissues, whereas COX‐2 is rapidly induced after stimulation of quiescent cells by growth factors and also by oncogenes, carcinogens and tumour‐promoters (<a href="./references#CD004121-bbs2-0030" title="HiaT , NeilsonK . Human cyclooxygenase‐2 cDNA. Proceedings of National Academy of Science USA1992;89(16):7384‐8. [PUBMED: 1380156] ">Hia 1992</a>; <a href="./references#CD004121-bbs2-0029" title="HerschmanHR . Prostaglandin synthase 2. Biochimica et Biophysica Acta1996;1299(1):125‐40. [PUBMED: 8555245] ">Hershmann 1996</a>). </p> <p>Over‐expression of COX‐2 is thought to be a key factor in malignant transformation in many tissues (<a href="./references#CD004121-bbs2-0045" title="MohammedSI , KnappDW , BostwickDG , FosterRS , KhanKN , MasferrerJL , et al. Expression of cyclooxygenase‐2 (COX‐2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Research1999;59(22):5647‐50. [MEDLINE: 10582676] ">Mohammed 1999</a>; <a href="./references#CD004121-bbs2-0041" title="LimHY , JooHJ , ChoiJH , YiJW , YangMS , ChoDY , et al. Increased expression of cyclooxygenase‐2 protein in human gastric carcinoma. Clinical Cancer Research2000;6(2):519‐25. [MEDLINE: 10690533] ">Lim 2000</a>; <a href="./references#CD004121-bbs2-0056" title="ShammaA , YamamotoH , DokiY , OkamiJ , KondoM , FujiwaraY , et al. Up‐regulation of cyclooxygenase‐2 in squamous carcinogenesis of the oesophagus. Clinical Cancer Research2000;6(4):1229‐38. [MEDLINE: 10778945] ">Shamma 2000</a>; <a href="./references#CD004121-bbs2-0057" title="ShariatSF , KimJH , AyalaGE , KhoK , WheelerTM , LernerSP . Cyclooxygenase‐2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. Journal of Urology2003;169(3):938‐42. [MEDLINE: 12576817] ">Shariat 2003</a>; <a href="./references#CD004121-bbs2-0058" title="ShirahamaT . Cyclooxygenase‐2 expression is up‐regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clinical Cancer Research2000;6(6):2424‐30. [MEDLINE: 10873095] ">Shirahama 2000</a>; <a href="./references#CD004121-bbs2-0063" title="SurhY‐J , KunduJM . Signal transduction network leading to COX‐2 induction: a road map in search of cancer chemopreventives. Archives of Pharmacal Research2005;28(1):1‐15. [PUBMED: 15742801] ">Surh 2005</a>; <a href="./references#CD004121-bbs2-0064" title="TanKB , PuttiTC . Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications. Journal of Clinical Pathology2005;58(5):535‐8. [MEDLINE: 15858127] ">Tan 2005</a>). Increased levels of COX‐2 protein expression have been reported in malignancies arising in various sites such as the stomach (<a href="./references#CD004121-bbs2-0041" title="LimHY , JooHJ , ChoiJH , YiJW , YangMS , ChoDY , et al. Increased expression of cyclooxygenase‐2 protein in human gastric carcinoma. Clinical Cancer Research2000;6(2):519‐25. [MEDLINE: 10690533] ">Lim 2000</a>), breast (<a href="./references#CD004121-bbs2-0033" title="HwangD , ScollardD , ByrneJ , LevineE . Expression of cyclooxygenase‐1 and cyclooxygenase‐2 in human breast cancer. Journal of the National Cancer Institute1998;90(6):455‐60. [MEDLINE: 9521170] ">Hwang 1998</a>), oesophagus (<a href="./references#CD004121-bbs2-0056" title="ShammaA , YamamotoH , DokiY , OkamiJ , KondoM , FujiwaraY , et al. Up‐regulation of cyclooxygenase‐2 in squamous carcinogenesis of the oesophagus. Clinical Cancer Research2000;6(4):1229‐38. [MEDLINE: 10778945] ">Shamma 2000</a>), ovary <a href="./references#CD004121-bbs2-0046" title="MunkarahA , Ali‐FehmiR . COX‐2: a protein with an active role in gynecological cancers. Current Opinion in Obstetrics and Gynecology2005;17(1):49‐53. [PUBMED: 15711411] ">Munkarah 2005</a>, cervix (<a href="./references#CD004121-bbs2-0020" title="FerrandinaG , LauriolaL , ZannoniGF , DistefanoMG , LeggeF , SalutariV , et al. Expression of cyclooxygenase‐2 (COX‐2) in tumour and stroma compartments in cervical cancer: clinical implications. Cancer2002;87(10):1145‐52. [MEDLINE: 12402155] ">Ferrandina 2000</a>; <a href="./references#CD004121-bbs2-0021" title="FerrandinaG , LauriolaL , DistefanoMF , ZannoniGF , GessiM , LeggeF , et al. Increased cyclooxygenase‐2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. Journal of Clinical Oncology2002;20(4):973‐81. [MEDLINE: 11844819] ">Ferrandina 2002</a>; <a href="./references#CD004121-bbs2-0040" title="KulkarniS , RaderJS , ZhangF , LiapisH , KokiAT , MasferrerJL , et al. Cyclooxygenase‐2 is overexpressed in human cervical cancer. Clinical Cancer Research2001;7:429‐34. [MEDLINE: 11234900] ">Kulkarni 2001</a>; <a href="./references#CD004121-bbs2-0055" title="RyuHS , ChangKH , YangHW , KimMS , KwonHC , OhKS . High cyclooxygenase‐2 expression in stage 1B cervical cancer with lymph node metastasis or parametrial invasion. Gynecologic Oncology2000;76(3):320‐5. [MEDLINE: 10684704] ">Ryu 2000)</a>, and colon (<a href="./references#CD004121-bbs2-0016" title="EberhartCE , CoffeyRJ , RadhikA . Up‐regulation of cyclooxygenase‐2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology1994;107(4):1183‐8. [PUBMED: 7926468] ">Eberhart 1994</a>; <a href="./references#CD004121-bbs2-0060" title="SoslowRA , DannenbergAJ , RushD , WoernerBM , KhanKN , MasferrerJ , et al. COX‐2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer2000;89(12):2637‐45. [MEDLINE: 11135226] ">Soslow 2000)</a>. </p> <p>COX‐2 may play a role in malignant transformation in the cervix. Increased COX‐2 expression is found with higher grades of CIN (<a href="./references#CD004121-bbs2-0018" title="FarleyJ , UyeharaC , HashiroG , BelnapC , BirrerM , SalminenE . Cyclooxygenase‐2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure. Gynecologic Oncology2004;92(2):596‐602. [MEDLINE: 14766253] ">Farley 2004</a>; <a href="./references#CD004121-bbs2-0044" title="MitchellA , NewtonJM , BriteK , EinspahrJ , EllisM , DavisJ , et al. Cyclooxygenase 2 expression in cervical intraepithelial neoplasia and vulvar cancer. Journal of Lower Genital Tract Disease2007;11(2):80‐5. [MEDLINE: 17415111] ">Mitchell 2007</a>). There is an increased risk of persistent or recurrent disease when resection margins (following excisional procedures) are positive for the enzyme (<a href="./references#CD004121-bbs2-0018" title="FarleyJ , UyeharaC , HashiroG , BelnapC , BirrerM , SalminenE . Cyclooxygenase‐2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure. Gynecologic Oncology2004;92(2):596‐602. [MEDLINE: 14766253] ">Farley 2004</a>). COX‐2 is present in invasive carcinoma (<a href="./references#CD004121-bbs2-0015" title="DursunP , YuceK , UsubutunA , AyhanA . Cyclooxygenase‐2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables. International Journal of Gynecological Cancer2007;17(1):164‐73. [MEDLINE: 17291249] ">Dursun 2007</a>; <a href="./references#CD004121-bbs2-0018" title="FarleyJ , UyeharaC , HashiroG , BelnapC , BirrerM , SalminenE . Cyclooxygenase‐2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure. Gynecologic Oncology2004;92(2):596‐602. [MEDLINE: 14766253] ">Farley 2004</a>; <a href="./references#CD004121-bbs2-0039" title="KimJY , LimSJ , ParkK , LeeCM , KimJ . Cyclooxygenase‐2 and c‐erbB‐2 expression in uterine cervical neoplasm assessed using tissue microarrays. Gynecologic Oncology2005;97(2):337‐41. [MEDLINE: 15863127] ">Kim 2005</a>; <a href="./references#CD004121-bbs2-0040" title="KulkarniS , RaderJS , ZhangF , LiapisH , KokiAT , MasferrerJL , et al. Cyclooxygenase‐2 is overexpressed in human cervical cancer. Clinical Cancer Research2001;7:429‐34. [MEDLINE: 11234900] ">Kulkarni 2001</a>; <a href="./references#CD004121-bbs2-0044" title="MitchellA , NewtonJM , BriteK , EinspahrJ , EllisM , DavisJ , et al. Cyclooxygenase 2 expression in cervical intraepithelial neoplasia and vulvar cancer. Journal of Lower Genital Tract Disease2007;11(2):80‐5. [MEDLINE: 17415111] ">Mitchell 2007</a>). Similar to other cancers (<a href="./references#CD004121-bbs2-0013" title="CaoY , PrescottSM . Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer. Journal of Cell Physiology2002;190(3):279‐86. [PUBMED: 11857443] ">Cao 2002</a>; <a href="./references#CD004121-bbs2-0059" title="SobolewskiC , CerellaC , DicatoM , GhibelliL , DiederichM . The role of cyclooxygenase‐2 in cell proliferation and cell death in human malignancies. International Journal of Cell Biology 2010 Mar 17 [Epub ahead of print]. [PUBMED: 20339581] ">Sobolewski 2010</a>), high levels of expression are associated with poorer prognostic features such as shorter time to first recurrence, decreased survival (<a href="./references#CD004121-bbs2-0018" title="FarleyJ , UyeharaC , HashiroG , BelnapC , BirrerM , SalminenE . Cyclooxygenase‐2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure. Gynecologic Oncology2004;92(2):596‐602. [MEDLINE: 14766253] ">Farley 2004</a>; <a href="./references#CD004121-bbs2-0020" title="FerrandinaG , LauriolaL , ZannoniGF , DistefanoMG , LeggeF , SalutariV , et al. Expression of cyclooxygenase‐2 (COX‐2) in tumour and stroma compartments in cervical cancer: clinical implications. Cancer2002;87(10):1145‐52. [MEDLINE: 12402155] ">Ferrandina 2000</a>; <a href="./references#CD004121-bbs2-0021" title="FerrandinaG , LauriolaL , DistefanoMF , ZannoniGF , GessiM , LeggeF , et al. Increased cyclooxygenase‐2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. Journal of Clinical Oncology2002;20(4):973‐81. [MEDLINE: 11844819] ">Ferrandina 2002</a>; <a href="./references#CD004121-bbs2-0025" title="GaffneyDK , HoldenJ , DaviesM . Elevated cyclooxygenase‐2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy. International Journal of Radiation, Oncology, Biology and Physics2001;49(5):1213‐7. [PUBMED: 11286825] ">Gaffney 2001</a>), increased lymph node metastasis or parametrial invasion (<a href="./references#CD004121-bbs2-0026" title="GaffneyDK , HaslamD , TsodikovA , HammondE , SeamanJ , HoldenJ , et al. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. International Journal of Radiation Oncology Biology Physics2003;56(4):922‐8. [PUBMED: 12829126] ">Gaffney 2003</a>; <a href="./references#CD004121-bbs2-0038" title="KimMH , SeoSS , SongYS , KangDH , ParkIA , KangSB , et al. Expression of cyclooxygenase‐1 and ‐2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecologic Oncology2003;90(1):83‐90. [PUBMED: PMID: 12821346] ">Kim 2003</a>; <a href="./references#CD004121-bbs2-0055" title="RyuHS , ChangKH , YangHW , KimMS , KwonHC , OhKS . High cyclooxygenase‐2 expression in stage 1B cervical cancer with lymph node metastasis or parametrial invasion. Gynecologic Oncology2000;76(3):320‐5. [MEDLINE: 10684704] ">Ryu 2000</a>), and chemotherapy or radiation resistance (<a href="./references#CD004121-bbs2-0020" title="FerrandinaG , LauriolaL , ZannoniGF , DistefanoMG , LeggeF , SalutariV , et al. Expression of cyclooxygenase‐2 (COX‐2) in tumour and stroma compartments in cervical cancer: clinical implications. Cancer2002;87(10):1145‐52. [MEDLINE: 12402155] ">Ferrandina 2000</a>; <a href="./references#CD004121-bbs2-0037" title="KimYB , KimGE , ChoNH , PyoHR , ShimSJ , ChangSK , et al. Overexpression of cyclooxygenase‐2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Cancer2002;95(3):531‐9. [MEDLINE: 12209745] ">Kim 2002</a>). </p> <p>The mechanism of the effect on the development of tumours is still being investigated, but it has already been shown that increased expression of COX‐2 will inhibit apoptosis (<a href="./references#CD004121-bbs2-0065" title="TsujiiM , DuboisRN . Alterations in cellular adhesion and apoptosis in epithelial cells over expressing prostaglandin endoperoxide synthase 2. Cell1995;83(3):493‐501. [PUBMED: 8521479] ">Tsujii 1995)</a>, promote angiogenesis (<a href="./references#CD004121-bbs2-0067" title="TsujiiM , KawanoS , TsujiiS , SawaokaH , HoriM , DuboisRN . Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell1998;93(5):705‐16. [PUBMED: 9630216] ">Tsujii 1998</a>), and enhance the invasiveness of malignant cells (<a href="./references#CD004121-bbs2-0066" title="TsujiiM , KawanoS , DuBoisRN . Cyclooxygenase‐2 expression in human colon cancer cells increases metastatic potential. Proceedings of National Academy of Science USA1997;94(7):3336‐40. [PUBMED: 9096394] ">Tsujii 1997</a>). It has been hypothesised that over‐expression of COX‐2 could impair host immune responses (<a href="./references#CD004121-bbs2-0032" title="HuangD , SkollardD , SharmaS . Non‐small cell lung cancer cyclooxygenase‐2‐dependent regulation of cytokine balance in lymphocytes and macrophages: up regulation of interleukins 10 and down regulation of interleukins 12 production. Cancer Research1998;58(6):1208‐16. [MEDLINE: 9515807] ">Huang 1998</a>; <a href="./references#CD004121-bbs2-0051" title="PockajBA , BasuGD , PathangeyLB , GrayRJ , HernandezJL , GendlerSJ , et al. Reduced T‐cell and dendritic cell function is related to cyclooxygenase‐2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Annals of Surgical Oncology2004;11(3):328‐39. [MEDLINE: 14993030] ">Pockaj 2004</a>), partly because COX‐2 inhibitors reverse tumour‐associated immunosuppression (<a href="./references#CD004121-bbs2-0032" title="HuangD , SkollardD , SharmaS . Non‐small cell lung cancer cyclooxygenase‐2‐dependent regulation of cytokine balance in lymphocytes and macrophages: up regulation of interleukins 10 and down regulation of interleukins 12 production. Cancer Research1998;58(6):1208‐16. [MEDLINE: 9515807] ">Huang 1998</a>; <a href="./references#CD004121-bbs2-0062" title="StolinaM , SharmaS , LinY , DohadwalaM , GardnerB , LuoJ , et al. Specific inhibition of cyclooxygenase‐2 restores tumor reactivity by altering the balance of IL‐10 and IL‐12 synthesis. Journal of Immunology2000;164(1):361‐70. [PUBMED: 10605031] ">Stolina 2000</a>). </p> <p>The inhibition of the prostaglandin biosynthetic cascade by NSAIDs has been demonstrated to modulate carcinogenesis in both human and animal epithelial tissues (<a href="./references#CD004121-bbs2-0036" title="KelloffGJ , BooneCW , CrowellJA , SteeleVE , LubetRA , DoodyLA . New agents for cancer chemoprevention. Journal of Cellular Biochemistry1996;26S:1‐28. [MEDLINE: 97298750] ">Kelloff 1996</a>). Selective COX‐2 inhibitors suppress tumorigenesis in experimental models of colon, bladder, breast, prostate, stomach, skin, and lung cancers (<a href="./references#CD004121-bbs2-0017" title="ElmetsCA , VinerJL , PentlandAP , CantrellW , LinHY , BaileyH , et al. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double‐blind, placebo‐controlled trial. Journal of the National Cancer Institute2010;102(24):1835‐44. [PUBMED: 21115882] ">Elmets 2010</a>; <a href="./references#CD004121-bbs2-0022" title="FischerSM , LoHH , GordonGB , SeibertK , KelloffG , LubertRA , et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, and indomethacin against ultraviolet‐light induced skin carcinogenesis. Molecular Carcinogenesis1999;25(4):231‐40. [PUBMED: 10449029] ">Fischer 1999</a>; <a href="./references#CD004121-bbs2-0023" title="FischerSM , HawkET , LubetRA . Coxibs and other nonsteroidal anti‐inflammatory drugs in animal models of cancer prevention. Cancer Prevention Research2011;4(11):1728‐35. [PUBMED: 21778329] ">Fischer 2011</a>; <a href="./references#CD004121-bbs2-0028" title="HarrisRE , AlshafieGA , Abou‐IsaaH , SeibertK . Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Research2000;60(8):2101‐3. [PUBMED: 10786667] ">Harris 2000</a>; <a href="./references#CD004121-bbs2-0035" title="KawamoriT , RaoCV , SeibertK , ReddyBS . Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor against colon carcinogenesis. Cancer Research1998;58(3):409‐12. [PUBMED: 9458081] ">Kawamori 1998</a>; <a href="./references#CD004121-bbs2-0042" title="LiuXH , KirschenbaumA , YaoS , LeeR , HollandJF , LevineAC . Inhibition of cyclooxygenase‐2 suppresses angiogenesis and the growth of prostate cancer in vivo. Journal of Urology2000;164(3):820‐5. [PUBMED: 10953162] ">Liu 2000</a>; <a href="./references#CD004121-bbs2-0048" title="NarisawaT , SatoM , TaniM , KudoT , TakahashiT , GotoA . Inhibition of development of methylnitrosourea‐induced rat colon tumors by indomethacin treatment. Cancer Research1981;41(5):1954‐7. [PUBMED: 7214363] ">Narisawa 1981</a>; <a href="./references#CD004121-bbs2-0049" title="OkajimaE , DendaA , OzonoS , TakahamaM , AkaiH , SasakiY , et al. Chemopreventive effects of nimesulide, a selective cyclooxygenase‐2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N‐butyl‐N‐(4‐hydroxybutyl) nitrosamine. Cancer Research1998;58(14):3028‐31. [PUBMED: 9679967] ">Okajima 1998</a>; <a href="./references#CD004121-bbs2-0053" title="ReddyBS , HiroseY , LubetR , SteeleV , KelloffG , PaulsonS , et al. Chemoprevention of colon cancer by specific cyclooxygenase‐2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Research2000;60(2):293‐7. [PUBMED: 10667579] ">Reddy 2000.</a> </p> <p>One of the proposed benefits of selective COX‐2 inhibitors was a reduction of significant gastrointestinal toxicity related to blocking of COX‐1 from non‐selective NSAIDs (<a href="./references#CD004121-bbs2-0052" title="PsatyBM , PotterJD . Risks and benefits of celecoxib to prevent recurrent adenomas. New England Journal of Medicine2006;355(9):950‐2. [PUBMED: 16943408] ">Psaty 2006</a>). While this is true, COX‐2 inhibition is unfortunately associated with other adverse effects, principally related to inhibition of the production of prostacyclin in the arterial endothelial and smooth muscle cells (<a href="./references#CD004121-bbs2-0027" title="GrosserT , FriesS , FitzGeraldGA . Biological basis for the cardiovascular consequences of COX‐2 inhibition: therapeutic challenges and opportunities. Journal of Clinical Investigation2006;116(1):4‐15. [PUBMED: 16395396] ">Grosser 2006</a>). In two large randomised controlled trials (RCTs) investigating celecoxib for the prevention of colorectal adenomas, cardiovascular events (myocardial infarction, stroke, congestive heart failure, and death) were increased 12.7% in patients taking celecoxib, and reduced by 4.4% in those taking aspirin (<a href="./references#CD004121-bbs2-0009" title="ArberN , EagleCJ , SpicakJ , RáczI , DiteP , HajerJ , et al. PreSAP Trial Investigators. Celecoxib for the prevention of colorectal adenomatous polyps. New England Journal of Medicine2006;355:885‐95. [PUBMED: 16943401] ">Arber 2006</a>; <a href="./references#CD004121-bbs2-0011" title="BertagnolliMM , EagleCJ , ZauberAG , RedstonM , SolomonSD , KimK , et al. APC Study Investigators. Celecoxib for the prevention of sporadic colorectal adenomas. New England Journal of Medicine2006;355(9):873‐84. [PUBMED: 16943400] ">Bertagnolli 2006</a>; <a href="./references#CD004121-bbs2-0052" title="PsatyBM , PotterJD . Risks and benefits of celecoxib to prevent recurrent adenomas. New England Journal of Medicine2006;355(9):950‐2. [PUBMED: 16943408] ">Psaty 2006</a>). These patients had a median age of 59 to 61, were treated for relatively long periods of time (one to three years) and many had pre‐existing cardiovascular disease. While these patients represent a different population than most who would be treated for CIN, cardiovascular events remain a concern with the use of COX‐2 inhibitors. Rofecoxib, a COX‐2 inhibitor, which was used by one of the studies in this review, was withdrawn from the market in 2004 for such concerns. </p> <p>It should be noted that many women may experience regression of CIN without treatment: CIN 2 regression is estimated in around 50% of women within six months (<a href="./references#CD004121-bbs2-0012" title="BleeckerE , KoehlerE , SmithJ , BudwitD , RahangdaleL . Outcomes after management of young women with cervical intraepithelial neoplasia 2 with a 6‐month observation protocol. Journal of Lower Genital Tract Disease2014;18(1):46‐9. [PUBMED: 23959297] ">Bleecker 2014</a>) and CIN 3 regression in approximately 30% of women within six months. In a RCT investigating medical treatment for CIN 2/CIN 3, 31% in the placebo arm had complete histologic regression in six months (<a href="./references#CD004121-bbs2-0024" title="FollenM , AtkinsonEN , SchottenfeldD , MalpicaA , WestL , LippmanS , et al. A randomized clinical trial of 4‐hydroxyphenylretinamide for high‐grade squamous intraepithelial lesions of the cervix. Clinical Cancer Research2001;7(11):3356‐65. [PUBMED: 11705848] ">Follen 2001</a>), whilst in another similar study 32% of CIN 2/CIN 3 lesions regressed to a lower level of CIN in three months without treatment (<a href="./references#CD004121-bbs2-0008" title="AlvarezRD , ConnerMG , WeissH , KlugPM , NiwasS , ManneU , et al. The efficacy of 9‐cis retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double blind clinical trial. Cancer, Epidemiology, Biomarkers &amp; Prevention2003;12(2):114‐9. [PUBMED: 12582020] ">Alvarez 2003</a>). Differences in regression may be related to the subtype of high risk human papillomavirus (HPV) as HPV‐16 and HPV‐33 are less likely to be spontaneously cleared and more likely to progress to higher CIN (<a href="./references#CD004121-bbs2-0034" title="JaisamrarnU , CastellsaguéX , GarlandSM , NaudP , PalmrothJ , DelRosario‐RaymundoMR , et al. HPV PATRICIA Study Group. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLOS One2013;8(11):e79260. [PUBMED: 24260180] ">Jaisamrarn 2013</a>). </p> </section> <section id="CD004121-sec-0027"> <h3 class="title" id="CD004121-sec-0027">Why it is important to do this review</h3> <p>The potential use of NSAIDs, including COX‐2 inhibitors, to induce regression or prevent the progression of CIN to invasive carcinoma is an exciting prospect. To our knowledge, no recent systematic review has been published that specifically addresses this subject. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004121-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004121-sec-0028"></div> <p>To evaluate the effectiveness and safety of non‐steroidal anti‐inflammatory agents (NSAIDs), including cyclooxygenases inhibitors, to induce regression and prevent the progression of cervical intraepithelial neoplasia (CIN). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004121-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004121-sec-0029"></div> <section id="CD004121-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004121-sec-0031"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) or non‐RCTs.</p> <p>Studies were considered only if they included details of how the grading of CIN was determined. The gold standard for follow‐up of CIN includes cervical cytology, colposcopy and biopsy, where indicated. However, studies were accepted for review with cytologic assessment only. Progression was defined as elevation of the grade of dysplasia by at least one grade (CIN 1 to CIN 2, CIN 2 to CIN 3 and CIN 3 to invasive disease). Regression was defined as reduction in the grade of dysplasia by at least one grade (CIN 3 to CIN 2, CIN 2 to CIN 1, and CIN 1 to no dysplasia). </p> </section> <section id="CD004121-sec-0032"> <h4 class="title">Types of participants</h4> <p>Women 18 years of age and over with an initial diagnosis of CIN.</p> </section> <section id="CD004121-sec-0033"> <h4 class="title">Types of interventions</h4> <p>Treatment with non‐steroidal anti‐inflammatory agents (NSAIDs), including cyclooxygenase‐2 (COX‐2) inhibitors alone, by any route in an outpatient setting. </p> </section> <section id="CD004121-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD004121-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD004121-list-0001"> <li> <p>Progression of CIN to higher grades of CIN</p> </li> <li> <p>Progression of CIN to invasive carcinoma</p> </li> <li> <p>Regression of CIN</p> </li> </ul> </p> </section> <section id="CD004121-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p>Adverse events related to treatment.</p> </section> </section> </section> <section id="CD004121-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for papers in all languages and planned to have them translated as necessary.</p> <section id="CD004121-sec-0038"> <h4 class="title">Electronic searches</h4> <p>For the original query, we searched the Specialised Register of the Cochrane Gynaecological Cancer Review Group (CGCRG), the Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library 2013, Issue 11) (see <a href="./appendices#CD004121-sec-0080">Appendix 1</a>); MEDLINE (1946 up to Novemeber, 2013) (see <a href="./appendices#CD004121-sec-0081">Appendix 2</a>); and Embase (1980 up to 2013, week 48) (see <a href="./appendices#CD004121-sec-0082">Appendix 3</a>). An updated literature search was performed in August 2017 through CENTRAL (2017, Issue 8), MEDLINE (July week 3, 2017) and Embase (July week 31, 2017). </p> </section> <section id="CD004121-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We carried out an electronic search of abstracts presented to the annual or biennial meetings of the following organisations: Society of Gynecologic Oncologists, International Gynecological Cancer Society, European Society of Gynecologic Cancer, American Society of Colposcopy and Cervical Pathology, and the American Society of Clinical Oncology by reviewing their respective online journals of <i>Gynecologic Oncology, The International Journal of Gynecological Cancer, Journal of Lower Genital Tract Diseases and Journal of Clinical Oncology.</i> </p> <p>We searched the following databases for ongoing trials.</p> <p> <ul id="CD004121-list-0002"> <li> <p>Metaregister (http://<a href="http://www.controlled-trials.com/rct" target="_blank">www.controlled‐trials.com/rct</a>). </p> </li> <li> <p>Physicians Data Query (<a href="http://www.nci.nih.gov" target="_blank">http://www.nci.nih.gov</a>). </p> </li> <li> <p>http://<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>. </p> </li> <li> <p>http://<a href="http://www.cancer.gov/clinicaltrials" target="_blank">www.cancer.gov/clinicaltrials</a>. </p> </li> </ul> </p> <section id="CD004121-sec-0040"> <h5 class="title">Handsearching</h5> <p>We checked the references from published studies to identify additional trials.</p> </section> </section> </section> <section id="CD004121-sec-0041"> <h3 class="title" id="CD004121-sec-0041">Data collection and analysis</h3> <p>The methodology of the review was based on the guidelines stated in the <i>Cochrane Handbook for Systematic Reviews of Interventions 5.1.0</i> (<a href="./references#CD004121-bbs2-0031" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We downloaded all titles and abstracts retrieved by electronic searching and removed duplicates. Three review authors (originally OMS and CWH, and recently SMG and CWH) examined the remaining references independently. We excluded those studies which clearly did not meet the inclusion criteria and obtained copies of the full text of potentially relevant references. Three review authors (originally OMS and CWH, and recently SMG and CWH) independently assessed the eligibility of retrieved papers. The review authors resolved disagreements by discussion. There was no disagreement that required resolution from a third review author. We documented reasons for exclusion. </p> <section id="CD004121-sec-0042"> <h4 class="title">Selection of studies</h4> <p>Three review authors (originally OMS and CWH, and recently SMG and CWH) searched the titles and abstracts from the initial computerised searches for potential trials to include. The review authors then independently assessed the full text of these provisionally included studies to determine whether a study met the inclusion criteria. We resolved disagreement by consensus. </p> </section> <section id="CD004121-sec-0043"> <h4 class="title">Data extraction and management</h4> <p>We analysed the included studies for the following data.</p> <p> <ul id="CD004121-list-0003"> <li> <p>Author, year of publication and journal citation (including language)</p> </li> <li> <p>Country</p> </li> <li> <p>Setting</p> </li> <li> <p>Inclusion and exclusion criteria</p> </li> <li> <p>Study design, methodology</p> </li> <li> <p>Study population</p> <ul id="CD004121-list-0004"> <li> <p>Total number enrolled</p> </li> <li> <p>Patient characteristics</p> </li> <li> <p>Age</p> </li> <li> <p>Co‐morbidities</p> </li> <li> <p>Other baseline characteristics</p> </li> </ul> </li> <li> <p>Intervention details</p> <ul id="CD004121-list-0005"> <li> <p>Patients receiving NSAIDs of any type or route for the purposes of CIN treatment were considered in the intervention group </p> </li> </ul> </li> <li> <p>Comparison</p> <ul id="CD004121-list-0006"> <li> <p>Patients used as the controls in the selected studies (not receiving NSAIDs) were used as the comparison </p> </li> </ul> </li> <li> <p>Risk of bias</p> </li> <li> <p>Duration of accrual</p> </li> <li> <p>Compliance</p> </li> <li> <p>Duration of follow‐up</p> </li> <li> <p>Outcomes: For each outcome we extracted the outcome definition</p> </li> <li> <p>Results: We extracted the number of participants allocated to each intervention group, the total number analysed for each outcome, and the missing participants </p> </li> </ul> </p> <p>If reported, we extracted both unadjusted and adjusted statistics.</p> <p>Where possible, all data extracted were relevant to an intention‐to‐treat analysis, in which participants are analysed in the groups to which they were assigned. </p> <p>Three review authors (initially OMS and CWH and later SMG and CWH) independently extracted data onto a data abstraction form specially designed for the review. Differences between review authors were resolved by discussion. </p> </section> <section id="CD004121-sec-0044"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the risk of bias in included RCTs using Cochrane's 'Risk of bias' tool and the criteria specified in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004121-bbs2-0031" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). This included assessment of the following domains. </p> <p> <ul id="CD004121-list-0007"> <li> <p>Selection bias: Random sequence generation and allocation concealment</p> </li> <li> <p>Performance bias: Blinding of participants and personnel (patients and treatment providers)</p> </li> <li> <p>Detection bias: Blinding of outcome assessment</p> </li> <li> <p>Attrition bias: Incomplete outcome data. We recorded the proportion of participants whose outcomes were not reported at the end of the study and considered greater than 20% attrition to be at a high risk of bias </p> </li> <li> <p>Reporting bias: Selective reporting of outcomes</p> </li> <li> <p>Other possible sources of bias</p> </li> </ul> </p> <p>Three review authors (initially OMS and CWH and later SMG and CWH) applied the 'Risk of bias' tool (<a href="./appendices#CD004121-sec-0083">Appendix 4</a>) independently and differences were resolved by discussion. We have presented results in a 'Risk of bias' graph and 'Risk of bias' summary and interpreted the results of the meta‐analyses in light of the findings with respect to risk of bias. </p> </section> <section id="CD004121-sec-0045"> <h4 class="title">Measures of treatment effect</h4> <p>We used the following measures of the effect of treatment.</p> <p> <ul id="CD004121-list-0008"> <li> <p>For time to event data, we planned to use the hazard ratio (HR), if possible.</p> </li> <li> <p>For dichotomous outcomes, we used the risk ratio (RR).</p> </li> </ul> </p> </section> <section id="CD004121-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>We did not impute missing outcome data for the primary outcome.</p> </section> <section id="CD004121-sec-0047"> <h4 class="title">Assessment of reporting biases</h4> <p>Given the description of outcomes reported in the studies, we did not examine funnel plots corresponding to meta‐analysis of the primary outcome to assess the potential for small‐study effects such as publication bias. </p> </section> <section id="CD004121-sec-0048"> <h4 class="title">Data synthesis</h4> <p>Statistical analysis was performed using Review Manager 5.3 software (<a href="./references#CD004121-bbs2-0054" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). Where appropriate, we pooled results of comparable trials using a fixed‐effect model. We reported results as RRs with their corresponding 95% confidence intervals (CIs). We performed the meta‐analysis using Review Manager 5.3 (<a href="./references#CD004121-bbs2-0054" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004121-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004121-sec-0049"></div> <section id="CD004121-sec-0050"> <h3 class="title">Description of studies</h3> <section id="CD004121-sec-0051"> <h4 class="title">Results of the search</h4> <p>For the previous version of this review (<a href="./references#CD004121-bbs2-0068" title="GraboschSM , ShariffOM , WulfJL , HelmCW . Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. Cochrane Database of Systematic Reviews2014, Issue 4. [DOI: 10.1002/14651858.CD004121.pub3] ">Grabosch 2014</a>), the search strategy identified references that we screened by title and abstract in order to identify studies as potentially eligible for the review. From 232 unique references, we identified six articles as potentially eligible for the review. Following the full‐text screening of these six articles, we excluded four for the reasons described in the table '<a href="./references#CD004121-sec-0101" title="">Characteristics of excluded studies</a>'. The remaining two RCTs met the inclusion criteria and are described in the table '<a href="./references#CD004121-sec-0100" title="">Characteristics of included studies</a>'. We did not identify any additional relevant studies fro the ancillary searches. </p> <p>With the updated search, we identified 35 new references with one article meeting the criteria for inclusion (<a href="#CD004121-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD004121-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD004121-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD004121-sec-0052"> <h4 class="title">Included studies</h4> <p>The initial two included RCTs randomised a total of 41 women; one study included 25 women (<a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>), and the other study 16 women (<a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>). The new study included in this version of the review (<a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>) involved 130 women resulting in a total of 171 women included in this review. All three studies used cyclooxygenase‐2 (COX‐2) inhibitors. </p> <p>The studies were performed as a multi‐institution United States trial (<a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>), and two single‐institution trials at Tripler United States Army Medical Center in Hawaii, USA (<a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>), and Medical University of Vienna, Austria (<a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>), respectively. The Austrian study was closed early when rofecoxib was withdrawn from the market, due to potential toxicity (<a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>). The mean age of the treatment and placebo groups was 23 years ± 4 years and 22.5 years ± 3 years (overall range 19 to 27 years) (<a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>), and 27.1 years ± 3.3 years and 31.2 years ± 5.5 years (overall range 24 to 36 years) (<a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>). The multi‐institution trial did not include a median age for the groups; however, overall age range was 18 to 49 years (<a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>). Thirty‐one patients had CIN 2, 25 patients had CIN 2‐3, and 76 had CIN 3. The treatment groups received celecoxib 400 mg once daily by mouth for 14 to 18 weeks (<a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>), celecoxib 200 mg twice daily by mouth for six months (<a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>), and rofecoxib 25 mg by mouth daily (<a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>). In all studies the comparison arm received placebo tablets (<a href="./references#CD004121-sec-0100" title="">Characteristics of included studies</a>). </p> </section> <section id="CD004121-sec-0053"> <h4 class="title">Excluded studies</h4> <p>We excluded four studies because they were reviews of chemoprevention (<a href="./references#CD004121-bbs2-0044" title="MitchellA , NewtonJM , BriteK , EinspahrJ , EllisM , DavisJ , et al. Cyclooxygenase 2 expression in cervical intraepithelial neoplasia and vulvar cancer. Journal of Lower Genital Tract Disease2007;11(2):80‐5. [MEDLINE: 17415111] ">Mitchell 2007</a>; <a href="./references#CD004121-bbs2-0007" title="VlastosAT , SchottenfeldD , FollenM . Biomarkers and their use in cervical cancer chemoprevention. Critical Reviews in Oncology Hematology2003;46(3):261‐73. [PUBMED: 12791426] ">Vlastos 2003</a>), a clinical study of celecoxib together with chemoradiation for the treatment of cervical cancer (<a href="./references#CD004121-bbs2-0005" title="HerreraFG , ChanP , DollC , MilosevicM , OzaA , SyedA , et al. A prospective phase I‐II trial of the cyclooxygenase‐2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment. International Journal of Radiation Oncology, Biology and Physics2006;67(1):97‐103. [PUBMED: 17056201] ">Herrera 2007</a>), and a laboratory investigation of celecoxib in cervical cancer cell lines (<a href="./references#CD004121-bbs2-0004" title="FerrandinaG , RanellettiFO , LeggeF , LauriolaL , SalutariV , GessiM , et al. Celecoxib modulates the expression of cyclooxygenase‐2, ki67, apoptosis‐related marker, and microvessel density in human cervical cancer: a pilot study. Clinical Cancer Research2003;9(12):4324‐31. [PUBMED: 14555502] ">Ferrandina 2003</a>) (<a href="./references#CD004121-sec-0101" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD004121-sec-0054"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed the risk of bias as being lower in the completed study (<a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>), as the randomisation code in the other study (<a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>) was broken when rofecoxib could no longer be given to patients (<a href="./references#CD004121-sec-0100" title="">Characteristics of included studies</a>), (<a href="#CD004121-fig-0002">Figure 2</a>; <a href="#CD004121-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD004121-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004121-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD004121-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004121-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>Overall, the multi‐institution trial (<a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>) had a low risk of bias, but it should be noted that 91 of 130 (70%) enrolled completed the study with evaluable tissue thus contributing to possible attrition bias. </p> <section id="CD004121-sec-0055"> <h4 class="title">Allocation</h4> <section id="CD004121-sec-0056"> <h5 class="title">Sequence generation</h5> <p>Adequacy of randomisation was confirmed in all three studies (<a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>; <a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>; <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>). </p> </section> <section id="CD004121-sec-0057"> <h5 class="title">Allocation</h5> <p>Concealment of allocation was low risk in <a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>, and <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>, but was unclear for <a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>. (<a href="./references#CD004121-sec-0100" title="">Characteristics of included studies</a>) </p> </section> </section> <section id="CD004121-sec-0058"> <h4 class="title">Blinding</h4> <p>Performance bias was assessed as being at low risk of bias in <a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a> and <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a> where both patients and the examining physicians were blinded to the treatment arm to which the patients were randomised, and unclear in <a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>, since the statistician and pathologist were blinded at all times, but the randomisation code was broken (<a href="./references#CD004121-sec-0100" title="">Characteristics of included studies</a>). </p> <p>Detection bias was assessed as low risk of bias with physicians, patients and pathologist blinded at all times in <a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a> and <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>, but unclear in <a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a> because of the broken code (<a href="./references#CD004121-sec-0100" title="">Characteristics of included studies</a>). </p> </section> <section id="CD004121-sec-0059"> <h4 class="title">Incomplete outcome data</h4> <p>Attrition bias was assessed as high risk in <a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a> because "five patients (20%) discontinued the study early but were included in the final statistical analysis" and unclear in <a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a> (<a href="./references#CD004121-sec-0100" title="">Characteristics of included studies</a>). For <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>, we have assessed this as low risk given that the higher number of patients included in the study decreases the potential for bias even with a high loss of eligible/evaluable patients and that the analysis was performed on both the patients completing the trial and as an intent‐to‐treat analysis. </p> </section> <section id="CD004121-sec-0060"> <h4 class="title">Selective reporting</h4> <p>There was insufficient information to assess in the studies.</p> </section> <section id="CD004121-sec-0061"> <h4 class="title">Other potential sources of bias</h4> <p>One study closed early (<a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>), but otherwise, there are insufficient data to identify whether other sources of bias exist. </p> </section> </section> <section id="CD004121-sec-0062"> <h3 class="title" id="CD004121-sec-0062">Effects of interventions</h3> <p>See: <a href="./full#CD004121-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <section id="CD004121-sec-0063"> <h4 class="title">Efficacy</h4> <section id="CD004121-sec-0064"> <h5 class="title">Primary outcomes</h5> <section id="CD004121-sec-0065"> <h6 class="title">1. Progression of CIN to higher grades of cervical intraepithelial neoplasia (CIN)</h6> <p>Progression to a higher grade of CIN occurred in one out of 12 (8%) of those receiving celecoxib and two out of 13 (15%) receiving placebo (risk ratio (RR) 0.54, 95% confidence interval (CI) 0.06 to 5.24; P value 0.60) (<a href="./references#CD004121-fig-0004" title="">Analysis 1.1</a>, one study, 25 participants; very low‐certainty evidence). </p> <p>The Heffler study did not comment on progression (<a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>). There was no progression of disease in <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>. </p> <p><b>2. Progression of CIN to invasive carcinoma</b> </p> <p>Neither single‐institution study reported on progression to invasive cancer (<a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>; <a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>). There was no progression of disease in <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>. </p> </section> <section id="CD004121-sec-0066"> <h6 class="title">3. Regression of CIN</h6> <p>Partial or complete regression of CIN 2 or CIN 3 occurred in 31 out of 70 (44%) in the treatment arms and 19 of 62 (31%) in the placebo arms (RR 1.45, 95% CI 0.93 to 2.27; P value 0.10) (<a href="./references#CD004121-fig-0005" title="">Analysis 2.1</a>: three studies, 132 participants; moderate‐certainty evidence). </p> <p>Complete regression of CIN 2 or CIN 3 occurred in 15 of 62 (24%) of those receiving celecoxib versus 10 of 54 (19%) of those receiving placebo (RR 1.31, 95% CI 0.65 to 2.67; P value 0.45 (<a href="./references#CD004121-fig-0006" title="">Analysis 2.2</a>; two studies, 116 participants; moderate‐certainty evidence). </p> <p>Partial regression of CIN 2 or CIN 3 occurred in 14 of 62 (23%) of those receiving celecoxib versus 8 of 54 (15%) of those receiving placebo (RR 1.56, 95% CI 0.72 to 3.40; P value 0.26) (<a href="./references#CD004121-fig-0007" title="">Analysis 2.3</a>, two studies, 116 participants; moderate certainty evidence). </p> </section> </section> <section id="CD004121-sec-0067"> <h5 class="title">Secondary outcome</h5> <p>Adverse events related to treatment were not reported in either single‐institution study (<a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>; <a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>). Other than one Grade 3 adverse event in the treatment group of <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>, the grade 1 and 2 toxicities were similar between the treatment and placebo arms. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004121-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004121-sec-0068"></div> <p>The pursuit of non‐invasive methods to prevent the progression of cervical intraepithelial neoplasia (CIN) remains important in order to allow women to avoid the potentially serious morbidities of invasive treatments, including pain, bleeding, infection, cervical stenosis and premature birth in a subsequent pregnancy, and to reduce the healthcare costs involved in the prevention of invasive carcinoma of the cervix. Although there are sound theoretical reasons why non‐steroidal anti‐inflammatory agents (NSAIDs) might have an effect on prevention of progression of CIN (as detailed in the <a href="#CD004121-sec-0023">Background</a>), the findings of this review are not surprising in view of the small size and quality of the published data that were identified. The questions can only be resolved through the performance of appropriately designed clinical trials; such trials are difficult to perform in this setting. </p> <p>It is important to note that any therapeutic benefit demonstrated as a result of further clinical trials will need to be weighed against the possible adverse effects of both NSAIDs and cyclooxygenase‐2 (COX‐2) inhibitors that have been identified in large chemoprevention studies for colorectal adenomas. </p> <p>In light of the causal association of high‐risk human papilloma virus (HPV) infection with the development and progression of CIN (<a href="./references#CD004121-bbs2-0047" title="MunozN , CastellsagueX , deGonzalezAB , GissmannL . Chapter 1: HPV in the etiology of human cancer. Vaccine2006;24(Suppl 3):S1‐S10. [PUBMED: 16949995] ">Munoz 2006</a>), and the high negative predictive value of clearance of high‐risk HPV infection following treatment, such testing might be an important factor to incorporate in future studies (<a href="./references#CD004121-bbs2-0050" title="ParaskevaidisE , ArbynM , SotiriadisA , DiakomanolisE , Martin‐HirschP , KoliopoulosG , et al. The role of HPV DNA testing in the follow‐up period after treatment for CIN: a systematic review of the literature. Cancer Treatment Reviews2004;30:205‐11. [PUBMED: 15023438] ">Paraskevaidis 2004</a>). However, HPV‐16 status did not seem to contribute to celecoxib response with 36.2% and 38.5% responding with and without the virus in the newly reviewed trial (<a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>). </p> <section id="CD004121-sec-0069"> <h3 class="title" id="CD004121-sec-0069">Summary of main results</h3> <p>We found no convincing evidence to support the use of NSAIDS in CIN 2/3 to induce complete or partial regression, or to prevent progression to higher grades. </p> </section> <section id="CD004121-sec-0070"> <h3 class="title" id="CD004121-sec-0070">Overall completeness and applicability of evidence</h3> <p>This update includes recently published data which adds to the body of literature that unfortunately, while well‐tolerated, NSAIDs do not prove effective in the treatment of CIN significantly more than the disease is naturally cleared while on placebo. With the addition of this larger trial, the authors feel that this topic has been adequately explored. </p> </section> <section id="CD004121-sec-0071"> <h3 class="title" id="CD004121-sec-0071">Quality of the evidence</h3> <p>The trials in our original review appear to have been well‐conducted although they were of small size and one was closed early due to withdrawal of the study agent. With the addition of the multi‐institution randomised trial in this update (<a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>), we have upgraded the evidence to moderate certainty according to GRADE criteria given that the addition of the new trial quadrupled the number of patients in our original review and was a well‐designed multi‐centre trial (<a href="./full#CD004121-tbl-0001">summary of findings Table for the main comparison</a>). Given that the natural history of CIN lends to some regression without intervention and no convincing evidence that NSAIDs have a significant impact over placebo, we do not feel that further research would alter the conclusions. </p> </section> <section id="CD004121-sec-0072"> <h3 class="title" id="CD004121-sec-0072">Potential biases in the review process</h3> <p>We undertook a comprehensive search to identify eligible studies. Three review authors extracted data independently. It is possible that there are other incomplete and unreported studies that have not been identified. We chose to retain data from the use of rofecoxib (removed from the market in 2004) in the review as findings may be similar to other COX‐2 inhibitors. </p> </section> <section id="CD004121-sec-0073"> <h3 class="title" id="CD004121-sec-0073">Agreements and disagreements with other studies or reviews</h3> <p>We did not identify any relevant studies or reviews.</p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004121-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/urn:x-wiley:14651858:media:CD004121:CD004121-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_t/tCD004121-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD004121-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004121-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/urn:x-wiley:14651858:media:CD004121:CD004121-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_t/tCD004121-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004121-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004121-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/urn:x-wiley:14651858:media:CD004121:CD004121-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_t/tCD004121-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004121-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004121-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/urn:x-wiley:14651858:media:CD004121:CD004121-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_t/tCD004121-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Progression of CIN, Outcome 1 Progression of CIN to higher grade of CIN." data-id="CD004121-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Progression of CIN, Outcome 1 Progression of CIN to higher grade of CIN.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/references#CD004121-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004121-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/urn:x-wiley:14651858:media:CD004121:CD004121-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_t/tCD004121-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Regression of CIN 2 and 3, Outcome 1 Partial or complete regression of CIN 2 or CIN 3." data-id="CD004121-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Regression of CIN 2 and 3, Outcome 1 Partial or complete regression of CIN 2 or CIN 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/references#CD004121-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004121-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/urn:x-wiley:14651858:media:CD004121:CD004121-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_t/tCD004121-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Regression of CIN 2 and 3, Outcome 2 Complete regression of CIN 2 or CIN 3." data-id="CD004121-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Regression of CIN 2 and 3, Outcome 2 Complete regression of CIN 2 or CIN 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/references#CD004121-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004121-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/urn:x-wiley:14651858:media:CD004121:CD004121-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_t/tCD004121-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Regression of CIN 2 and 3, Outcome 3 Partial regression of CIN 2 or CIN 3." data-id="CD004121-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Regression of CIN 2 and 3, Outcome 3 Partial regression of CIN 2 or CIN 3. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/references#CD004121-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/media/CDSR/CD004121/image_n/nCD004121-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004121-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Non‐steroidal anti‐inflammatory agents (NSAIDs) compared with placebo for CIN 2 or CIN 3</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with CIN 2 or CIN 3 </p> <p><b>Settings:</b> outpatient </p> <p><b>Intervention:</b> celecoxib 400 mg by mouth daily for 14‐18 weeks, celecoxib 200 mg by mouth twice daily for six months or rofecoxib 40 mg by mouth daily for three months </p> <p><b>Comparison:</b> placebo tablet by mouth, daily for three to six months </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of Participants<br/> (studies)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Progression of CIN to a higher grade of CIN</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>77 per 1000<sup>1</sup> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>42 per 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.54 (0.06 to 5.24)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 (one study)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<sup>3</sup><br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Partial or complete regression of CIN 2 or CIN 3</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>308 per 1000<sup>2</sup> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>447 per 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.45 (0.93 to 2.27)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>132 (three studies)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<sup>3</sup><br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Complete regression of CIN 2 or CIN 3</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>174 per 1000<sup>1</sup> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>228 per 1000</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.31 (0.65 to 2.67)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>116 (two studies)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>3</sup><br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>CIN</b> : cervical intraepithelial neoplasia; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High</b> certainty<b>:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate</b> certainty<b>:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low</b> certainty<b>:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low</b> certainty<b>:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The basis for the assumed risk is from the spontaneous complete regression rate in the placebo arm of <a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a> and <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a> </p> <p><sup>2</sup> The basis for the assumed risk is from the combined spontaneous partial or complete regression rates in the placebo arms of <a href="./references#CD004121-bbs2-0001" title="FarleyJH , TruongV , GooE , UyeharaC , BelnapC , LarsenWI . A randomized double‐blind placebo‐controlled phase II trial of the cyclooxygenase‐2 inhibitor Celecoxib in the treatment of cervical neoplasia. Gynecologic Oncology2006;103(2):425‐30. [PUBMED: 16677697] ">Farley 2006</a>; <a href="./references#CD004121-bbs2-0002" title="HeflerLA , GrimmC , SpeiserP , SliutzG , ReinthallerA . The cyclooxygenase‐2 inhibitor rofecoxib (Vioxx) in the treatment of cervical dysplasia grade II‐III. A phase II trial. European Journal of Obstetrics and Gynecology and Reproductive Biology2005;125(2):251‐4. [PUBMED: 16188370] ">Hefler 2006</a>; <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a> </p> <p><sup>3</sup>Given the increased sample size with the addition of <a href="./references#CD004121-bbs2-0003" title="RaderJS , SillMW , BeumerJH , LankesHA , BenbrookDM , GarciaF , et al. A stratified randomized double‐blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology2017;145(2):291‐7. ">Rader 2017</a>, we have upgraded the certainty to high other than the Progression analysis as it is based on one small study and thus remained very low certainty. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/full#CD004121-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004121-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Progression of CIN</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Progression of CIN to higher grade of CIN <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.06, 5.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Progression of CIN</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/references#CD004121-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004121-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Regression of CIN 2 and 3</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Partial or complete regression of CIN 2 or CIN 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.93, 2.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Complete regression of CIN 2 or CIN 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.65, 2.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Partial regression of CIN 2 or CIN 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.72, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Regression of CIN 2 and 3</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004121.pub4/references#CD004121-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004121.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004121-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004121-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD004121-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD004121-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD004121-note-0007">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004121-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004121\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004121\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004121\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004121\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004121\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004121.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004121.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004121.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004121.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004121.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718578039"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004121.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718578042"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004121.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd3be3d22f401',t:'MTc0MDcxODU3OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 